908 Devices (MASS) Liabilities and Shareholders Equity (2020 - 2026)

908 Devices' (MASS) quarterly Liabilities and Shareholders Equity came in at $186.7 million in Q1 2026, down 4.76% year-on-year from $196.0 million in Q1 2025, and down 1.78% on a QoQ basis from $190.1 million in Q4 2025.

908 Devices (MASS) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

908 Devices (MASS) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $186.7 million in Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 4.76% year-over-year to $186.7 million in Q1 2026; TTM through Mar 2026 was $759.3 million, a 2.26% increase from a year earlier, with the FY2025 full-year figure at $190.1 million, up 19.18% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $186.7 million, down from $190.1 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for MASS reached as high as $251.2 million in Q1 2022 and fell as low as $159.5 million in Q4 2024.
  • Historically, Liabilities and Shareholders Equity has averaged $207.2 million across 5 years, with a median of $203.0 million in 2023.
  • Across the five-year window, Liabilities and Shareholders Equity surged 49.9% in 2022 and declined 21.43% in 2024, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $242.6 million in 2022, then declined by 16.33% to $203.0 million in 2023, then retreated by 21.43% to $159.5 million in 2024, then gained by 19.18% to $190.1 million in 2025, then dropped by 1.78% to $186.7 million in 2026.
  • Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $186.7 million in Q1 2026, $190.1 million in Q4 2025, and $190.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 181.32 Bn 174.03 Bn 6.27 Bn 110.43 Bn
2 Stryker 128.59 Bn 125.71 Bn 3.81 Bn 46.29 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 67.77 Bn 66.32 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 48.13 Bn 44.46 Bn 1.29 Bn 13.32 Bn
6 GE HealthCare Technologies 28.44 Bn 26.15 Bn 1.98 Bn 37.13 Bn
7 Dexcom 28.41 Bn 27.29 Bn 750.30 Mn 6.63 Bn
8 Smith & Nephew 26.77 Bn 26.20 Bn - 10.46 Bn
9 Koninklijke Philips 25.24 Bn 22.11 Bn 2.07 Bn 31.92 Bn
10 908 Devices 269.51 Mn 157.77 Mn 6.88 Mn 186.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 186.70 Mn
Dec 31, 2025 190.07 Mn
Sep 30, 2025 190.87 Mn
Jun 30, 2025 191.70 Mn
Mar 31, 2025 196.03 Mn
Dec 31, 2024 159.48 Mn
Sep 30, 2024 178.28 Mn
Jun 30, 2024 208.77 Mn
Mar 31, 2024 189.79 Mn
Dec 31, 2023 202.98 Mn
Sep 30, 2023 208.48 Mn
Jun 30, 2023 210.83 Mn
Mar 31, 2023 218.41 Mn
Dec 31, 2022 242.59 Mn
Sep 30, 2022 249.28 Mn
Jun 30, 2022 247.00 Mn
Mar 31, 2022 251.23 Mn
Dec 31, 2021 260.91 Mn
Sep 30, 2021 166.30 Mn
Jun 30, 2021 166.48 Mn